Cancer survival in Lower Silesia: insights from a national oncology network pilot in Poland
Distinct clinical trajectories of BC subtypes have significant implications for prognosis and healthcare resource allocation. The observation of ≥92% five-year survival for stage I disease across subtypes underscores the critical importance of early detection, particularly in biologically aggressive subtypes such as TNBC breast cancer.
Authors
- R Plisko
- Adam Maciejczyk (ORCID: https://orcid.org/0000-0002-7047-0433)
- Paweł Prędkiewicz (ORCID: https://orcid.org/0000-0002-8965-665X)
- Paweł Zawadzki
- D. Błaszczyk (ORCID: https://orcid.org/0000-0001-7396-1660)
- Bożena Cybulska-Stopa (ORCID: https://orcid.org/0000-0002-0975-850X)
- Magdalena Władysiuk (ORCID: https://orcid.org/0000-0002-9699-6708)
- Rafał Matkowski
Institutions
- Wrocław University of Science and Technology (PL)
- Jagiellonian University (PL)
- Wroclaw University of Economics and Business (PL)
- Wroclaw Medical University (PL)
- Lublin Oncology Center (PL)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2026-02-18
- DOI
- https://doi.org/10.3389/fonc.2026.1739198
- Primary Topic
- Breast Cancer Treatment Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00